Mirae Asset Capital Life Science, Inc., Mirae Asset Venture Investments
VC · New York (United States)
Sign up free to access full profile and submit your pitch.
About
Mirae Asset Capital Life Science, Inc. is a venture capital firm specializing in growth capital, series A, series B, series C, and seed investments. The firm allocates 50% of its capital for investments in series A, 25% for series B, 15% for series C and 10% for seed investments. It prefers to invest in biotechnology, therapeutics (modality agnostic), drug development, clinical data, market dynamics, oncology, immunology, CV/metabolic, CNS/ophthalmology, rare/genetic disease, digital health, AI/ML tools, quantum computing, generative biology/chemistry, occupational therapy services, combinatorial chemistry and other lead generating technologies, diagnostics (opportunistic), life science and healthcare sectors. The firm seeks to invest in the U.S. (primary) and Europe/Canada (opportunistic). The firm also so-invests with life science investors. The firm seeks to invest up to $10 million in companies. The firm was founded in 2023 and is based in New York, New York with additional offices in San Francisco, California; Menlo Park, California and Boston, Massachusetts. Mirae Asset Capital Life Science, Inc. is a joint venture between Mirae Asset Capital and Mirae Asset Global Investments.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
.png)
